Digestive and Liver Disease
Volume 43, Issue 8, 2011, Pages 589-595

Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates) (Article)

Almasio P.L. , Babudieri S. , Barbarini G. , Brunetto M. , Conte D. , Dentico P. , Gaeta G.B. , Leonardi C. , Levrero M. , Mazzotta F. , Morrone A. , Nosotti L.* , Prati D. , Rapicetta M. , Sagnelli E. , Scotto G. , Starnini G.
  • a Gastroenterology and Hepatology Unit, University of Palermo, Palermo, Italy
  • b Department of Infectious Diseases, University of Sassari, Sassari, Italy
  • c Department of Infectious and Tropical Diseases, San Matteo Foundation, Pavia, Italy
  • d Gastroenterology and Hepatology Unit, Pisa University Hospital, Pisa, Italy
  • e Gastroenterology Department, University of Milan, Milan, Italy
  • f Infectious Disease Department, University of Bari, Bari, Italy
  • g Infectious Disease Department, 2nd University of Naples, Naples, Italy
  • h Drug Addiction and Alcoholism Prevention and Treatment Operating Unit, RMC Local Health Service, Rome, Italy
  • i Department of Internal Medicine, Sapienza University, Rome, Italy
  • j Infectious Disease Department, SM Annunziata Hospital, Florence, Italy
  • k National Institute for Health, Migration and Poverty-NIHMP, Rome, Italy
  • l National Institute for Health, Migration and Poverty-NIHMP, Rome, Italy
  • m Transfusion and Hematology Department, A. Manzoni Hospital, Lecco, Italy
  • n Infectious Disease Department, Istituto Superiore di Sanità, Rome, Italy
  • o Infectious Disease Department, S. Sebastiano Hospital, Caserta, Italy
  • p Infectious Disease Clinic, University of Foggia, Foggia, Italy
  • q Guarded Department of Infectious Diseases, Belcolle Hospital, Viterbo, Italy

Abstract

The global spread of hepatitis B virus (HBV) and hepatitis C virus (HCV), their high chronicity rates and their progression to cirrhosis and hepatocellular carcinoma, are major public health problems. Research and intervention programmes for special population groups are needed in order to assess their infection risk and set up suitable prevention and control strategies.Aim of this paper is to give health care professionals information on HBV and HCV infections amongst migrants, drug users and prison inmates. The manuscript is an official Position Paper on behalf of the following Scientific Societies: Italian Association for the Study of the Liver (A.I.S.F.), Italian Society of Infectious and Tropical Diseases (S.I.M.I.T.), Italian Federation Department's Operators and Addiction Services (FederSerD), Italian Prison Medicine and Healthcare Society (S.I.M.S.Pe.).The considered population groups, having a high prevalence HBV and HCV infections, require specific interventions. In this context, the expression " special population" refers to specific vulnerable groups at risk of social exclusion, such as migrants, prison inmates, and intravenous drug users. When dealing with special population groups, social, environmental and clinical factors should be considered when selecting candidates for therapy as indicated by national and international guidelines. © 2010 Editrice Gastroenterologica Italiana S.r.l.

Author Keywords

HCV Migrants HBV Prison inmates Intravenous drug users

Index Keywords

Vulnerable Populations immigrant Cost benefit analysis human hepatitis A hepatitis B vaccine hepatitis A prisoner Practice Guidelines as Topic medical society Prisoners priority journal Hepatitis C, Chronic alcoholism escitalopram drug dependence patient counseling social status treatment duration influenza vaccine treatment indication Humans Socioeconomic Factors liver biopsy risk factor short course therapy cultural factor virus RNA patient education Article Substance Abuse, Intravenous patient compliance buprenorphine Hepatitis B, Chronic methadone hepatitis B surface antibody hepatitis B surface antigen Pneumococcus vaccine antiviral therapy Drug Users Italy Transients and Migrants vaccination hepatitis B olanzapine aripiprazole practice guideline intravenous drug abuse treatment contraindication cost effectiveness analysis hepatitis C
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960369225&doi=10.1016%2fj.dld.2010.12.004&partnerID=40&md5=84e0b008c996b302b6addf5b601cb52c
DOI: 10.1016/j.dld.2010.12.004
ISSN: 15908658
Cited by: 31
Original Language: English